BioWorld

April 1, 2008

View Archived Issues

Tekmira and Provita Merge to Form RNAi Powerhouse

Canadian firms Tekmira Pharmaceuticals Corp. and Protiva Biotherapeutics Inc. are merging to become a stronger international player in the RNA interference therapeutics space. (BioWorld Today) Read More

Merck, Schering Knocked by Vytorin Data, Physician Panel

Read More

Even in Hindsight, No Problems with Co-Stimulation in Rodents

Read More

$10M Deal: Acusphere Licenses HDDS, Compound to Cephalon

Read More

Transave Garners $35M to Aid Pipeline Push in Lung Diseases

Read More

Other News To Note

Read More

Clinic Roundup

Read More